Skip to content

Clinical trials

Completed Hematologic Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Status: Completed Country / region: United Kingdom Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20062
20072
20081
20091
20101
20114
20122
20133
20141
20154
20162
20201
20212
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene3
Kiadis Pharma3
Amgen2
Novartis Pharmaceuticals2
AGC Biologics S.p.A.1
Adaptimmune1
AstraZeneca1
Bayer1
Bristol-Myers Squibb1
Chroma Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms29
Neoplasms9
Leukemia, Myeloid, Acute7
Myelodysplastic Syndromes7
Precursor Cell Lymphoblastic Leukemia-Lymphoma5
Graft vs Host Disease3
Leukemia3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive3
Lymphoma3
Bone Marrow Diseases2

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.